摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzyl-5-oxopyrrolidine-2-carbonyl chloride | 135350-26-4

中文名称
——
中文别名
——
英文名称
1-benzyl-5-oxopyrrolidine-2-carbonyl chloride
英文别名
N-benzylpyroglutamic acid chloride;1-Benzyl-5-oxo-pyrrolidine-2-carbonylchloride
1-benzyl-5-oxopyrrolidine-2-carbonyl chloride化学式
CAS
135350-26-4
化学式
C12H12ClNO2
mdl
——
分子量
237.686
InChiKey
LCTWWLWBABTHST-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Rigo, Benoit; Kolocouris, Nicolas, Journal of Heterocyclic Chemistry, 1983, vol. 20, p. 893 - 898
    摘要:
    DOI:
  • 作为产物:
    描述:
    5-氧代吡咯烷-2-羧酸乙酯氯化亚砜 、 sodium hydride 、 sodium hydroxide 作用下, 以 为溶剂, 反应 29.5h, 生成 1-benzyl-5-oxopyrrolidine-2-carbonyl chloride
    参考文献:
    名称:
    Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligands
    摘要:
    A series of 17-cyclopropylmethyl-3,14 beta-dihydroxy-4,5 alpha-epoxy-6 alpha-(isoquinoline-3 '-carboxamido)morphinan (NAQ) analogues were synthesized and pharmacologically characterized to study their structure-activity relationship at the mu opioid receptor (MOR). The competition binding assay showed two-atom spacer and aromatic side chain were optimal for MOR selectivity. Meanwhile, substitutions at the 1 '- and/or 4 '-position of the isoquinoline ring retained or improved MOR selectivity over the kappa opioid receptor while still possessing above 20-fold MOR selectivity over the delta opioid receptor. In contrast, substitutions at the 6 '- and/or 7 '-position of the isoquinoline ring reduced MOR selectivity as well as MOR efficacy. Among this series of ligands, compound 11 acted as an antagonist when challenged with morphine in warm-water tail immersion assay and produced less significant withdrawal symptoms compared to naltrexone in morphine-pelleted mice. Compound 11 also antagonized the intracellular Ca2+ increase induced by DAMGO. Molecular dynamics simulation studies of 11 in three opioid receptors indicated orientation of the 6 '-nitro group varied significantly in the different 'address' domains of the receptors and played a crucial role in the observed binding affinities and selectivity. Collectively, the current findings provide valuable insights for future development of NAQ-based MOR selective ligands. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2015.02.055
点击查看最新优质反应信息

文献信息

  • Exploiting the regioselectivity of pyroglutamate alkylations for the synthesis of 6-azabicyclo[3.2.1]octanes and 4-azabicyclo[3.3.0]octanes
    作者:Kurt G.R. Masschelein、Christian V. Stevens、Nicolai Dieltiens、Diederica D. Claeys
    DOI:10.1016/j.tet.2007.03.084
    日期:2007.5
    Depending on the N-protecting group of pyroglutamates, the reactivity can be directed to the formation of 6-azabicyclo[3.2.1]octanes or 4-azabicyclo[3.3.0]octanes, which are conformationally restricted glutamate analogues.
    取决于焦谷氨酸的N-保护基团,反应性可被导向形成构象受限的谷氨酸类似物的6-氮杂双环[3.2.1]辛烷或4-氮杂双环[3.3.0]辛烷。
  • A Convenient Method for the Conversion of a Carboxy Group into a 4,6-Di­methoxy-1,3,5-triazine Group: Application to <i>N</i>-Benzylpyroglutamic Acids
    作者:Philippe Gautret、Souhila Oudir、Benoît Rigo、Jean-Pierre Hénichart
    DOI:10.1055/s-2006-942519
    日期:2006.9
    Reaction of an activated form of carboxylic acids with a stoichiometric amount of zinc dimethyl imidodicarbonimidate (in CH2Cl2-pyridine with molecular sieves), led to 4,6-dimethoxy-1,3,5-triazines in high yields. This method has been applied to N-benzylpyroglutamic acids, in the preparation of potential antifungal products.
    将活化形式的羧酸与一定量的二甲基亚氨基二甲酰亚胺锌(在带有分子筛的 CH2Cl2 吡啶中)反应,可以高产率地制备出 4,6-二甲氧基-1,3,5-三嗪。这种方法已被应用于 N-苄基焦谷氨酸,以制备潜在的抗真菌产品。
  • Studies on Pyrrolidinones. A New Rearrangement of Pyrrolo[1,2-b]Isoquinolines Derivatives
    作者:Benoît Rigo、Didier Barbry、Daniel Couturier
    DOI:10.1080/00397919108019753
    日期:1991.3
    Abstract New lactones are obtained as by-products during the Friedel-Crafts cyclization of N-arylmethyl pyroglutamoyl chlorides. A mechanism based on N-acyliminium salts is proposed to explain their formation.
    摘要 在N-芳甲基焦谷氨酰氯的Friedel-Crafts环化过程中,副产物得到了新的内酯。提出了一种基于 N-acyliminium 盐的机制来解释它们的形成。
  • Syntheses of 1,2-diamino and 1,2-aminoalcohol derivatives in the piperidine and pyrrolidine series as anti-amnesic agents
    作者:Shikai Zhao、Jeremiah P. Freeman、C.L. Bacon、G.B. Fox、E. O'Driscoll、A.G. Foley、J. Kelly、U. Farrell、Ciaran Regan、Stephen A. Mizsak、Jacob Szmuszkovicz
    DOI:10.1016/s0968-0896(99)00079-6
    日期:1999.8
    Tacrine, one of the drugs available for Alzheimer's disease based on the cholinergic approach, suffers from considerable toxicity. Many analogues of tacrine has been prepared which retain the pharmacologically rich aminopyridine or aminoquinoline motifs. The current research is a continuation of our efforts in the area of 11-aminobenzoquinolizidines (4) and 10-aminobenzoindolizidines (5) (cf. ref 9). A serendipitous discovery led us to the biologically active open chain analogue 9, and we proceeded to elaborate on this molecule. Overall, the compounds we prepared were poor inhibitors of acetylcholinesterase as compared to tacrine. The single exception was compound 20 which exhibited an effect comparable to that of tacrine, but only at a dose in the order of 10(-3) M. However, despite the poor acetylcholinesterase inhibition by 9, this compound was found to be an effective antiamnesic agent. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • RIGO, BENOIT;BARBRY, DIDIER;COUTURIER, DANIEL, SYNTH. COMMUN., 21,(1991) N, C. 741-747
    作者:RIGO, BENOIT、BARBRY, DIDIER、COUTURIER, DANIEL
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物